Neuro-Oncology - RSS feed of articles
13 followers 4 articles/week
Radioligand therapies in meningioma – evidence and future directions

AbstractMeningiomas are the most common intracranial neoplasms in adults. While most meningiomas are cured by resection, further treatment by radiotherapy may be needed, particularly in WHO grade 2 and 3 tumors which have an increased risk of recurrence, even after conventional therapies. Still, there is an urgent need for novel therapeutic strategies...

Sat May 4, 2024 12:41
Meningioma: International Consortium on Meningiomas (ICOM) consensus review on scientific advances & treatment paradigms for clinicians, researchers, and patients

AbstractMeningiomas are the most common primary intracranial tumors in adults and are increasing in incidence due to the aging population and the rising availability of neuroimaging. While most exhibit non-malignant behaviour, a subset of meningiomas are biologically aggressive and lead to significant neurological morbidity and mortality. In recent...

Sat May 4, 2024 12:41
Immunotherapy drives mesenchymal tumour cell state shift and TME immune response in glioblastoma patients

AbstractBackgroundGlioblastoma is a highly aggressive type of brain tumour for which there is no curative treatment available. Immunotherapies have shown limited responses in unselected patients, and there is an urgent need to identify mechanisms of treatment resistance to design novel therapy strategies.MethodsHere we investigated the phenotypic and...

Thu May 2, 2024 15:57
EDA2R reflects the acute brain response to cranial irradiation in liquid biopsies

AbstractBackgroundCranial radiotherapy is standard of care for high-grade brain tumors and metastases; however, it induces debilitating neurocognitive impairments in cancer survivors, especially children. As the numbers of pediatric brain cancer survivors continue improving, the numbers of individuals developing life-long neurocognitive sequalae are...

Mon Apr 29, 2024 18:10
Phase I trial of dose escalation for preoperative stereotactic radiosurgery for patients with large brain metastases

AbstractBackgroundSingle session stereotactic radiosurgery (SRS) or surgical resection alone for brain metastases larger than 2 cm results in unsatisfactory local control. We conducted a phase I trial for brain metastases(>2cm) to determine the safety of preoperative SRS at escalating doses.MethodsRadiosurgery dose was escalated at 3 Gy increments...

Wed Apr 24, 2024 19:29

Build your own newsfeed

Ready to give it a go?
Start a 14-day trial, no credit card required.

Create account